GGrantIndex
← Leaderboards

Casey Koontz

Leidos, Inc.

$15,552,500
Attributed
$15,552,500
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.8M · FY201317
$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$15,552,500 · 2

By mechanism

N01$15,552,500 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “National Institute Of Allergy And Infectious Disease

Research focus

National Institute Of Allergy And Infectious DiseaseServicesProgramsPre-ClinicalBiological ProductsBaseCommunicable DiseasesContractsBiotechnologyTherapeutic DevelopmentVectorSmall Interfering RnaProduct DevelopmentPlasmidsAttenuatedNucleic AcidsMonoclonal AntibodiesLifePeptidesRecombinant ProteinsCell LineAntigensInfectionAnthrax Disease

Grant awards (17)

Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)$763,534
N01 · FY2017 · AI · contact PI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)$1,933,277
N01 · FY2016 · AI · contact PI
TASK 17: Manufacture of mAb Clinical Material$433,366
N01 · FY2016 · AI · contact PI
TASK 16: Production of Botulinum Complex$37,363
N01 · FY2016 · AI · contact PI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)$2,823,243
N01 · FY2015 · AI · contact PI
TASK 17: Manufacture of mAb Clinical Material$2,477,136
N01 · FY2015 · AI · contact PI
Task X18: Development of Biopharmaceutical Products Program$204,322
N01 · FY2015 · AI · contact PI
TASK 16: Production of Botulinum Complex$198,722
N01 · FY2015 · AI · contact PI
Task 9: Product Validation - Biopharmaceutical Product Development Services program$100,369
N01 · FY2015 · AI · contact PI
Task X19: UNIVERSAL INFLUENZA IGY ANTIBODIES FOR THERAPEUTIC APPLICATIONS$36,591
N01 · FY2015 · AI · contact PI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)$3,529,059
N01 · FY2014 · AI · contact PI
Task X14: Monoclonal Antibody for HCV$394,062
N01 · FY2014 · AI · contact PI
NIAID Biopharmaceutical Product Development Services$244,801
N01 · FY2014 · AI · contact PI
TASK X12: THERAPEUTICS FOR NOROVIRUS$52,225
N01 · FY2014 · AI · contact PI
Task X11: Anti-Ricin Monoclonal Antibody Product Development$52,225
N01 · FY2014 · AI · contact PI
TASK X13: MANUFACTURE OF ANTI-POLIOVIRUS ANTIBODIES$27,584
N01 · FY2014 · AI · contact PI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)$2,244,621
N01 · FY2013 · AI · contact PI